These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 17715358

  • 1. Human 5-HT transporter availability predicts amygdala reactivity in vivo.
    Rhodes RA, Murthy NV, Dresner MA, Selvaraj S, Stavrakakis N, Babar S, Cowen PJ, Grasby PM.
    J Neurosci; 2007 Aug 22; 27(34):9233-7. PubMed ID: 17715358
    [Abstract] [Full Text] [Related]

  • 2. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
    Schneck N, Miller JM, Delorenzo C, Kikuchi T, Sublette ME, Oquendo MA, Mann JJ, Parsey RV.
    J Affect Disord; 2016 Jan 15; 190():494-498. PubMed ID: 26561939
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, Grasby P, Cowen P.
    Am J Psychiatry; 2007 Dec 15; 164(12):1858-65. PubMed ID: 18056241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Presynaptic Serotoninergic Regulation of Emotional Processing: A Multimodal Brain Imaging Study.
    Selvaraj S, Mouchlianitis E, Faulkner P, Turkheimer F, Cowen PJ, Roiser JP, Howes O.
    Biol Psychiatry; 2015 Oct 15; 78(8):563-571. PubMed ID: 24882568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A, Åhs F, Engman J, Jonasson M, Alaie I, Björkstrand J, Frans Ö, Faria V, Linnman C, Appel L, Wahlstedt K, Lubberink M, Fredrikson M, Furmark T.
    JAMA Psychiatry; 2015 Aug 15; 72(8):794-802. PubMed ID: 26083190
    [Abstract] [Full Text] [Related]

  • 10. Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use.
    Laursen HR, Henningsson S, Macoveanu J, Jernigan TL, Siebner HR, Holst KK, Skimminge A, Knudsen GM, Ramsoy TZ, Erritzoe D.
    J Psychopharmacol; 2016 Dec 15; 30(12):1296-1304. PubMed ID: 27599522
    [Abstract] [Full Text] [Related]

  • 11. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
    van de Giessen E, Rosell DR, Thompson JL, Xu X, Girgis RR, Ehrlich Y, Slifstein M, Abi-Dargham A, Siever LJ.
    J Psychiatr Res; 2014 Nov 15; 58():147-54. PubMed ID: 25145808
    [Abstract] [Full Text] [Related]

  • 12. Serotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activity.
    Oler JA, Fox AS, Shelton SE, Christian BT, Murali D, Oakes TR, Davidson RJ, Kalin NH.
    J Neurosci; 2009 Aug 12; 29(32):9961-6. PubMed ID: 19675230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metabolite considerations in the in vivo quantification of serotonin transporters using 11C-DASB and PET in humans.
    Parsey RV, Ojha A, Ogden RT, Erlandsson K, Kumar D, Landgrebe M, Van Heertum R, Mann JJ.
    J Nucl Med; 2006 Nov 12; 47(11):1796-802. PubMed ID: 17079812
    [Abstract] [Full Text] [Related]

  • 15. Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain.
    Yamamoto S, Onoe H, Tsukada H, Watanabe Y.
    Synapse; 2007 Sep 12; 61(9):724-31. PubMed ID: 17559093
    [Abstract] [Full Text] [Related]

  • 16. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G, Cannon DM, Allen AS, Klaver JM, Peck SA, Liu X, Manji HK, Drevets WC, McMahon FJ.
    Int J Neuropsychopharmacol; 2010 Jul 12; 13(6):715-24. PubMed ID: 20047709
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
    Reimold M, Batra A, Knobel A, Smolka MN, Zimmer A, Mann K, Solbach C, Reischl G, Schwärzler F, Gründer G, Machulla HJ, Bares R, Heinz A.
    Mol Psychiatry; 2008 Jun 12; 13(6):606-13, 557. PubMed ID: 18268503
    [Abstract] [Full Text] [Related]

  • 19. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P, Rullmann M, Drabe M, Luthardt J, Becker GA, Blüher M, Regenthal R, Sabri O, Hesse S.
    Neuropharmacology; 2016 Nov 12; 110(Pt A):530-536. PubMed ID: 27108933
    [Abstract] [Full Text] [Related]

  • 20. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
    Saijo T, Maeda J, Okauchi T, Maeda J, Morio Y, Kuwahara Y, Suzuki M, Goto N, Suzuki K, Higuchi M, Suhara T.
    Int J Neuropsychopharmacol; 2009 Sep 12; 12(8):1021-32. PubMed ID: 19236731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.